Deborah I. Barragan

805 total citations
8 papers, 641 citations indexed

About

Deborah I. Barragan is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Deborah I. Barragan has authored 8 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Deborah I. Barragan's work include Melanoma and MAPK Pathways (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Protein Tyrosine Phosphatases (2 papers). Deborah I. Barragan is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Protein Tyrosine Phosphatases (2 papers). Deborah I. Barragan collaborates with scholars based in United States, Canada and Australia. Deborah I. Barragan's co-authors include Paul A. Khavari, Phillip A. Dumesic, Florence A. Scholl, Daniel E. Webster, George L. Sen, Howard Y. Chang, Jean Charron, Kazutoshi Harada, Vickram Bissonauth and Rachel Farrell and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and The Journal of Cell Biology.

In The Last Decade

Deborah I. Barragan

8 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah I. Barragan United States 8 443 146 104 95 87 8 641
Lidia Lopez‐Serra Spain 12 776 1.8× 194 1.3× 68 0.7× 69 0.7× 64 0.7× 12 861
Sanae Uchida Japan 11 449 1.0× 46 0.3× 128 1.2× 107 1.1× 53 0.6× 15 586
H. Annika Siitonen Finland 9 357 0.8× 79 0.5× 91 0.9× 38 0.4× 98 1.1× 10 482
Yitzhak Reizel Israel 14 477 1.1× 108 0.7× 34 0.3× 49 0.5× 103 1.2× 21 665
Temuujin Dansranjavin Germany 12 308 0.7× 80 0.5× 45 0.4× 21 0.2× 59 0.7× 15 426
Haruki Kaku Japan 16 447 1.0× 189 1.3× 188 1.8× 29 0.3× 78 0.9× 35 757
E Emison United States 3 400 0.9× 172 1.2× 104 1.0× 19 0.2× 76 0.9× 5 681
Mônica Barbosa de Melo Brazil 16 362 0.8× 131 0.9× 70 0.7× 43 0.5× 30 0.3× 67 791
Vivien Grant United Kingdom 13 343 0.8× 67 0.5× 84 0.8× 22 0.2× 99 1.1× 19 686
Artur Darmanian Australia 11 315 0.7× 195 1.3× 231 2.2× 51 0.5× 87 1.0× 15 539

Countries citing papers authored by Deborah I. Barragan

Since Specialization
Citations

This map shows the geographic impact of Deborah I. Barragan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah I. Barragan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah I. Barragan more than expected).

Fields of papers citing papers by Deborah I. Barragan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah I. Barragan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah I. Barragan. The network helps show where Deborah I. Barragan may publish in the future.

Co-authorship network of co-authors of Deborah I. Barragan

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah I. Barragan. A scholar is included among the top collaborators of Deborah I. Barragan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah I. Barragan. Deborah I. Barragan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Farrell, Rachel, Anne Hunsaker Hawkins, Deborah I. Barragan, Louanne Hudgins, & Joanne Taylor. (2015). Knowledge, understanding, and uptake of noninvasive prenatal testing among Latina women. Prenatal Diagnosis. 35(8). 748–753. 37 indexed citations
2.
Weitzel, Jeffrey N., Jessica Clague, Arelis Martir-Negron, et al.. (2012). Prevalence and Type ofBRCAMutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network. Journal of Clinical Oncology. 31(2). 210–216. 115 indexed citations
3.
Barragan, Deborah I., Kelly E. Ormond, Michelle N. Strecker, & Jon Weil. (2011). Concurrent Use of Cultural Health Practices and Western Medicine During Pregnancy: Exploring the Mexican Experience in the United States. Journal of Genetic Counseling. 20(6). 609–624. 12 indexed citations
4.
Dumesic, Phillip A., Florence A. Scholl, Deborah I. Barragan, & Paul A. Khavari. (2009). Erk1/2 MAP kinases are required for epidermal G2/M progression. The Journal of Cell Biology. 185(3). 409–422. 80 indexed citations
5.
Scholl, Florence A., Phillip A. Dumesic, Deborah I. Barragan, Jean Charron, & Paul A. Khavari. (2009). Mek1/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin. Oncogene. 28(12). 1485–1495. 19 indexed citations
6.
Scholl, Florence A., Phillip A. Dumesic, Deborah I. Barragan, et al.. (2009). Selective Role for Mek1 but not Mek2 in the Induction of Epidermal Neoplasia. Cancer Research. 69(9). 3772–3778. 45 indexed citations
7.
Sen, George L., Daniel E. Webster, Deborah I. Barragan, Howard Y. Chang, & Paul A. Khavari. (2008). Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes & Development. 22(14). 1865–1870. 212 indexed citations
8.
Scholl, Florence A., Phillip A. Dumesic, Deborah I. Barragan, et al.. (2007). Mek1/2 MAPK Kinases Are Essential for Mammalian Development, Homeostasis, and Raf-Induced Hyperplasia. Developmental Cell. 12(4). 615–629. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lidia Lopez‐Serra Breakdown of academic impact, for papers by Sanae Uchida Breakdown of academic impact, for papers by H. Annika Siitonen Breakdown of academic impact, for papers by Yitzhak Reizel Breakdown of academic impact, for papers by Temuujin Dansranjavin Breakdown of academic impact, for papers by Haruki Kaku Breakdown of academic impact, for papers by E Emison Breakdown of academic impact, for papers by Mônica Barbosa de Melo Breakdown of academic impact, for papers by Vivien Grant Breakdown of academic impact, for papers by Artur Darmanian
Rankless by CCL
2026